# A Research Study of a Potential New Medicine (NNC4005-0001) for Liver Disease in Adult Participants With Increased Body Weight and Liver Fat

> **NCT07214870** · PHASE1 · RECRUITING · sponsor: **Novo Nordisk A/S** · enrollment: 60 (estimated)

## Conditions studied

- Fatty Liver Disease

## Interventions

- **DRUG:** NNC4005-001
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07214870
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-08
- **Primary completion:** 2027-05-14
- **Final completion:** 2027-05-14
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07214870

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07214870, "A Research Study of a Potential New Medicine (NNC4005-0001) for Liver Disease in Adult Participants With Increased Body Weight and Liver Fat". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07214870. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*